Feature Ensysce Biosciences’ transformative chemistry targeting drug safety and performance Ensysce Biosciences (NASDAQ:ENSC) is developing next-generation opioid products with its platform of two proprietary technologies to reduce abuse and overdose while relieving suffering for people with severe pain and... September 6, 2022